Education
About Us
Working with TipRanks
Follow Us
Verve Therapeutics, Inc. (VERV)
:VERV
VERV Stock Chart & Stats
$11.13
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Verve Therapeutics News
VERV FAQ
What was Verve Therapeutics, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Verve Therapeutics, Inc.’s market cap?
Currently, no data Available
When is Verve Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Verve Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Verve Therapeutics, Inc. overvalued?
According to Wall Street analysts Verve Therapeutics, Inc.’s price is currently Undervalued.
Does Verve Therapeutics, Inc. pay dividends?
Verve Therapeutics, Inc. does not currently pay dividends.
What is Verve Therapeutics, Inc.’s EPS estimate?
Verve Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Verve Therapeutics, Inc. have?
Currently, no data Available
What happened to Verve Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Verve Therapeutics, Inc.?
Currently, no hedge funds are holding shares in VERV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Verve Therapeutics, Inc.
Verve Therapeutics (VERV) is a biotechnology company focused on developing transformative genetic medicines for cardiovascular disease. The company leverages cutting-edge gene editing technologies to create single-course gene-editing medicines that have the potential to permanently reduce the risk of coronary artery disease. Verve's innovative approach aims to address the underlying genetic causes of cardiovascular disease, which is one of the leading causes of mortality worldwide.
Ownership Overview
―
Insiders
0.71%
Mutual Funds
― Other Institutional Investors
99.29% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---